Artificial Corneal Implants Market (By Transplant Type: Hard Keratoprosthesis, Soft Keratoprosthesis; By Indication: Ocular Burns, Keratoconus; By Implant Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global artificial corneal implants market size was estimated at around USD 67.95 million in 2022 and it is projected to hit around USD 135.68 million by 2032, growing at a CAGR of 7.16% from 2023 to 2032.

Key Pointers

  • The hard keratoprosthesis segment dominated the market and accounted for a revenue share of 87.5% in 2022.
  • In 2022, the keratoconus segment held the highest market share of 33.97%.
  • The synthetic segment dominated the market and accounted for a revenue share of 93.74% in 2022.
  • The hospital segment accounted for the highest revenue share of 57.6% in 2022 and is expected to register a lucrative CAGR over the forecast period.
  • North America dominated the artificial corneal implants market with the largest revenue share of 50.9% in 2022.

Artificial Corneal Implants Market Size 2023 to 2032

The increasing prevalence of corneal disorders, increasing demand for corneal transplants, and shortage of human corneas are significant factors driving the demand for the artificial corneal implants market. The COVID-19 pandemic had a significant negative impact on the artificial corneal implants market. The lockdowns and restrictions implemented by governments had a major impact on the market. With changes in healthcare priorities and the healthcare professionals dedicatedly working to treat and control the spread of the virus, elective surgeries were either canceled or postponed.

Moreover, in order to control the spread of the virus and as a preventive measure, many people avoided visits to hospitals or any other healthcare setting. This resulted in an overall drop in the number of corneal transplants that were carried out during the pandemic, which led to a negative impact on the market. However, due to the presence of a huge patient pool and a rising number of product launches, the artificial corneal implants market recovered at a great pace. In addition, with an increased focus on R&D in the healthcare sector by governments, the market is further expected to flourish over the forecast period.

The market is predominantly driven by a rise in the prevalence of eye disorders. An increase in the occurrence of eye-related disorders, such as keratoconus, ocular cicatricial pemphigoid, corneal stromal dystrophies, and infectious keratitis, is a major market driver. Studies suggest that Keratoconus affects approximately 50 to 200 per 100,000 individuals. In the U.S., the prevalence is about 54.5 per 100,000 individuals.

Corneal blindness is the third leading cause of blindness after glaucoma and cataract, affecting 10 million people globally. According to a research article published by the Eye Bank Association of America in 2021, an estimated 200,000 corneal implant procedures are performed annually. Artificial corneal implantation typically applies to patients who are not suited for a living corneal transplant from a human donor to regain their vision.

According to an article from Harvard Medical School, about 12.7 million individuals worldwide are waiting for corneal transplants, implying that only 1 in every 70 persons in need of a transplant is treated. Significant attempts have been made to create alternatives to human donor corneas to address the scarcity of donor tissue and the problems associated with corneal donor transplantation, thus augmenting the adoption of artificial corneal implants.

Furthermore, in low-risk patients with corneal blindness, corneal transplantation is successful, but it frequently fails in high-risk patients with recurring or chronic inflammatory disorders, as well as glaucoma. Another major factor driving the market growth is the large patient pool and limited supply of donors.

Artificial Corneal Implants Market Segmentations:

By Transplant Type

  • Hard Keratoprosthesis
    • Boston Kpro
    • Osteo-Odonto-Keratoprosthesis
  • Soft Keratoprosthesis

By Indication

  • Stevens-Johnson syndrome (SJS)
  • Ocular Cicatricial Pemphigoid (OCP)
  • Ocular burns
  • Keratoconus
  • Corneal stromal dystrophies
  • Others

By Implant Type

  • Synthetic
  • Biosynthetic

By Implant End-use

  • Hospitals
  • Ophthalmic Centers
  • Ambulatory Surgical Centers

Artificial Corneal Implants Market Key Players and Regions Segmentations:

Key Players Regions

FCI Ophthalmics, Inc.

Beijing Microkpro Medical Instrument Co. Ltd.

DIOPTEX Medizinprodukte Forschungs

KeraMed, Inc.

EyeYon

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

The global artificial corneal implants market size was reached at USD 67.95 million in 2022 and it is projected to hit around USD 135.68 million by 2032.

The global artificial corneal implants market is growing at a compound annual growth rate (CAGR) of 7.16% from 2023 to 2032.

The North America region has accounted for the largest artificial corneal implants market share in 2022.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Artificial Corneal Implants Market 

5.1. COVID-19 Landscape: Artificial Corneal Implants Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Artificial Corneal Implants Market, By Transplant Type

8.1. Artificial Corneal Implants Market, by Transplant Type, 2023-2032

8.1.1. Hard Keratoprosthesis

8.1.1.1. Market Revenue and Forecast (2019-2032)

8.1.2. Soft Keratoprosthesis

8.1.2.1. Market Revenue and Forecast (2019-2032)

Chapter 9. Global Artificial Corneal Implants Market, By Indication

9.1. Artificial Corneal Implants Market, by Indication, 2023-2032

9.1.1. Stevens-Johnson syndrome (SJS)

9.1.1.1. Market Revenue and Forecast (2019-2032)

9.1.2. Ocular Cicatricial Pemphigoid (OCP)

9.1.2.1. Market Revenue and Forecast (2019-2032)

9.1.3. Ocular burns

9.1.3.1. Market Revenue and Forecast (2019-2032)

9.1.4. Keratoconus

9.1.4.1. Market Revenue and Forecast (2019-2032)

9.1.5. Corneal stromal dystrophies

9.1.5.1. Market Revenue and Forecast (2019-2032)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2019-2032)

Chapter 10. Global Artificial Corneal Implants Market, By Implant Type 

10.1. Artificial Corneal Implants Market, by Implant Type, 2023-2032

10.1.1. Synthetic

10.1.1.1. Market Revenue and Forecast (2019-2032)

10.1.2. Biosynthetic

10.1.2.1. Market Revenue and Forecast (2019-2032)

Chapter 11. Global Artificial Corneal Implants Market, By Implant End-use 

11.1. Artificial Corneal Implants Market, by Implant End-use, 2023-2032

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2019-2032)

11.1.2. Ophthalmic Centers

11.1.2.1. Market Revenue and Forecast (2019-2032)

11.1.3. Ambulatory Surgical Centers

11.1.3.1. Market Revenue and Forecast (2019-2032)

Chapter 12. Global Artificial Corneal Implants Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.1.2. Market Revenue and Forecast, by Indication (2019-2032)

12.1.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.1.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.1.5.2. Market Revenue and Forecast, by Indication (2019-2032)

12.1.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.1.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.1.6.2. Market Revenue and Forecast, by Indication (2019-2032)

12.1.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.1.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.2.2. Market Revenue and Forecast, by Indication (2019-2032)

12.2.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.2.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.2.5.2. Market Revenue and Forecast, by Indication (2019-2032)

12.2.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.2.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.2.6.2. Market Revenue and Forecast, by Indication (2019-2032)

12.2.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.2.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.2.7.2. Market Revenue and Forecast, by Indication (2019-2032)

12.2.7.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.2.7.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.2.8.2. Market Revenue and Forecast, by Indication (2019-2032)

12.2.8.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.2.8.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.3.2. Market Revenue and Forecast, by Indication (2019-2032)

12.3.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.3.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.3.5.2. Market Revenue and Forecast, by Indication (2019-2032)

12.3.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.3.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.3.6.2. Market Revenue and Forecast, by Indication (2019-2032)

12.3.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.3.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.3.7.2. Market Revenue and Forecast, by Indication (2019-2032)

12.3.7.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.3.7.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.3.8.2. Market Revenue and Forecast, by Indication (2019-2032)

12.3.8.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.3.8.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.4.2. Market Revenue and Forecast, by Indication (2019-2032)

12.4.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.4.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.4.5.2. Market Revenue and Forecast, by Indication (2019-2032)

12.4.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.4.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.4.6.2. Market Revenue and Forecast, by Indication (2019-2032)

12.4.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.4.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.4.7.2. Market Revenue and Forecast, by Indication (2019-2032)

12.4.7.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.4.7.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.4.8.2. Market Revenue and Forecast, by Indication (2019-2032)

12.4.8.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.4.8.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.5.2. Market Revenue and Forecast, by Indication (2019-2032)

12.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.5.5.2. Market Revenue and Forecast, by Indication (2019-2032)

12.5.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.5.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)

12.5.6.2. Market Revenue and Forecast, by Indication (2019-2032)

12.5.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)

12.5.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)

Chapter 13. Company Profiles

13.1. FCI Ophthalmics, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Beijing Microkpro Medical Instrument Co. Ltd.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. DIOPTEX Medizinprodukte Forschungs

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. KeraMed, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. EyeYon

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert